Medicus Pharma (MDCX) Accounts Payables (2023 - 2026)
Medicus Pharma's (MDCX) quarterly Accounts Payables came in at $3.4 million in Q4 2025, up 167.42% YoY from $1.3 million in Q4 2024, and up 69.43% on a QoQ basis from $2.0 million in Q3 2025.
Medicus Pharma (MDCX) Accounts Payables (2023 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 3 years of Accounts Payables data on file, last reported at $3.4 million in Q4 2025.
- Quarterly Accounts Payables rose 167.42% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 167.42% YoY) and the FY2025 annual result came in at $3.4 million, up 167.42% from the prior year.
- Accounts Payables improved to $3.4 million in Q4 2025, from $2.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $3.4 million in Q4 2025 to a low of $210842.0 in Q4 2023.
- A 3-year average of $1.8 million and a median of $1.9 million in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables jumped 509.28% — and 2025, when it jumped 167.42%.
- Tracing MDCX's Accounts Payables over 3 years: stood at $210842.0 in 2023, then jumped by 509.28% to $1.3 million in 2024, then jumped by 167.42% to $3.4 million in 2025.
- The last three Accounts Payables figures came in at $3.4 million (Q4 2025), $2.0 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 22.89 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -19.24 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | 6.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.73 Mn |
| Dec 31, 2025 | 3.44 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 210,842.00 |